Sancy Bhd

Sancy Bhd maintains a strong liquidity position with a current ratio of 10.18, indicating significant short-term asset coverage over liabilities. However, the company reports negative net cash of MYR -391,670 (cash and equivalents MYR 751,300 minus long-term debt MYR 114,280). Free cash flow is negative at MYR -469,490, while operating cash flow remains robust at MYR 3,209,600. Profitability metrics show strong performance with a return on equity of 9.8% and return on assets of 9.35%, both exceeding the typical thresholds for healthcare technology firms. The company's operating margin of 63.4% (operating income MYR 2,192,170 / revenue MYR 3,456,850) demonstrates efficient cost management. The company's revenue is concentrated in digital healthcare solutions, with no disclosed geographic diversification beyond Malaysia. Non-clinical information management systems and hospital information systems represent the primary revenue streams, though segment-specific revenue breakdowns are not provided in the latest financials. Revenue growth trajectory is not explicitly quantified in the latest financials, but the company's operating income growth of 63.4% (operating income MYR 2,192,170 / revenue MYR 3,456,850) suggests strong operational leverage. Capital expenditures of MYR -3,277,970 indicate significant investment in infrastructure or system development. Risk assessment reveals medium liquidity risk due to negative net cash position and low dilution risk. The company has not issued additional shares in the latest reporting period, and no dilutive instruments are disclosed. However, the negative free cash flow raises concerns about long-term sustainability without external financing. Recent filings and transcripts are not provided in the input data, so no specific events can be cited. The company's focus on digital healthcare solutions aligns with industry trends toward digitization in healthcare, but its geographic concentration in Malaysia presents regulatory and market concentration risks.